0001209191-18-025141.txt : 20180417 0001209191-18-025141.hdr.sgml : 20180417 20180417142706 ACCESSION NUMBER: 0001209191-18-025141 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180417 FILED AS OF DATE: 20180417 DATE AS OF CHANGE: 20180417 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Motahari Saeed CENTRAL INDEX KEY: 0001704399 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35902 FILM NUMBER: 18758653 MAIL ADDRESS: STREET 1: C/O INSYS THERAPEUTICS, INC. STREET 2: 1333 SOUTH SPECTRUM BLVD, SUITE 100 CITY: CHANDLER STATE: AZ ZIP: 85286 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Insys Therapeutics, Inc. CENTRAL INDEX KEY: 0001516479 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510327886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 BUSINESS PHONE: 602-910-2617 MAIL ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-04-17 0 0001516479 Insys Therapeutics, Inc. INSY 0001704399 Motahari Saeed C/O INSYS THERAPEUTICS, INC. 1333 SOUTH SPECTRUM BLVD, SUITE 100 CHANDLER AZ 85286 1 1 0 0 President & CEO Common Stock 2018-04-17 4 A 0 11000 0.00 A 26400 D Restricted Stock Units 2018-04-17 4 D 0 11000 0.00 D Common Stock 11000 22000 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On April 17, 2017, the Reporting Person received a 33,000 share restricted stock unit award ("RSUs"). The RSUs vest in 3 equal annual installments beginning on April 17, 2018 and will be fully vested on April 17, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. /s/ Andrew Long, Attorney-in-fact 2018-04-17